跳至主要内容
临床试验/NCT00964938
NCT00964938已完成4 期

Multisite Pacing With a Quadripolar Left Heart Lead in Cardiovascular Resynchronization Therapy (CRT) Patients

Abbott Medical Devices1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2009年8月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
35
试验地点
1
主要终点
dP/dt max

研究概览

简要总结

The purpose of this study is to evaluate the effects of multisite left ventricular (LV) biventricular (BiV) pacing on LV hemodynamics in CRT patients. It is hypothesized that the effect of simultaneous BiV pacing utilizing multisite LV pacing on LV hemodynamics will be superior to conventional BiV pacing.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Have a scheduled CRT implantation at the participating clinical study site
  • •Have NYHA functional class III or IV, ejection fraction less than or equal to 35%, and QRS duration greater than 120ms
  • •Be undergoing a new St. Jude Medical CRT-D device system (including LV lead) implantation
  • •Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed perioperative evaluations

排除标准

  • •Have persistent or permanent atrial fibrillation
  • •Have an intrinsic heart rate of <50 beats per minute
  • •Have a recent myocardial infarction within 40 days prior to enrollment
  • •Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
  • •Have had a recent CVA or TIA within 3 months prior to enrollment
  • •Have had intravenous inotropic support in the last 30 days
  • •Have ischemic etiology and are unable to tolerate stress echocardiography

结局指标

主要结局

dP/dt max

时间窗: acute: during implant procedure; 1 day

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验